Two-year CAHtalyst data show crinecerfont sustained glucocorticoid reduction and improved metabolic outcomes in classic CAH.
Oksana Hamidi, DO
Advertisement
Oksana Hamidi, DO, is an associate professor in the division of endocrinology and metabolism at UT Southwestern Medical Center
Articles by Oksana Hamidi, DO
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
HAELO Phase 3: Lonvo-z Secondary Endpoints, QoL Data Detailed at EAACI
2
Mitraa-T1D: AI-Driven Converastional Tool Improves T1D Diabetes Distress, Self-Care Behaviors
3
Structuring Obesity Trials to Optimize Patient Retention and Data Integrity
4
Health Insurance Largely Controls Financial Toxicity in Patients With T1D
5